Suppr超能文献

在兔模型中通过直接抑制肾素抑制动脉瘤进展

Inhibition of Aneurysm Progression by Direct Renin Inhibition in a Rabbit Model.

作者信息

Miyake Takashi, Miyake Tetsuo, Shimizu Hideo, Morishita Ryuichi

机构信息

From the Department of Clinical Gene Therapy, Graduate School of Medicine, Osaka University, Japan.

出版信息

Hypertension. 2017 Dec;70(6):1201-1209. doi: 10.1161/HYPERTENSIONAHA.117.09815. Epub 2017 Oct 23.

Abstract

Angiotensin II is thought to participate in aneurysm formation, because of its ability to induce and perpetuate inflammation in the aortic wall. Because activation of renin is the first step of the renin-angiotensin system, renin inhibition could inhibit all components of this system effectively. Therefore, we examined the hypothesis that direct inhibition of renin activity could decrease the expansion of aortic aneurysm using a rabbit model. Aortic dilatation was induced by incubation with elastase around the rabbit abdominal aorta. Continuous administration of a direct renin inhibitor, aliskiren, was started at 1 week before incubation with elastase and continued for 5 weeks. Treatment with aliskiren markedly inhibited tissue renin activation and resulted in a significant reduction in angiotensin I and II production in the aneurysm wall. Consequently, the inhibition of renin activity prevented the expansion of experimental aortic aneurysm associated with preservation of the medial layer, independent of its blood pressure-lowering effect. Administration of aliskiren led to the inhibition of activation of NF-κB (nuclear factor-κB), AP-1 (activator protein-1), and CREB (cAMP response element-binding protein), which are thought to cooperatively regulate the inflammatory gene expression profile associated with aneurysm formation. As a result, treatment with aliskiren inhibited macrophage accumulation through suppression of MCP-1 (monocyte chemoattractant protein-1) and CCL4 (C-C motif chemokine ligand 4) expression, and TNF-α (tumor necrosis factor-α) production and activation of MMP-2 (matrix metalloproteinase-2) and MMP-9 (matrix metalloproteinase-9) were also suppressed in the aneurysm wall. In addition, inhibition of (pro)renin receptor elevation was also observed after treatment with aliskiren. Direct inhibition of renin activity using aliskiren prevented the progression of aortic aneurysm, suggesting it as a therapeutic option to treat abdominal aortic aneurysm.

摘要

血管紧张素II被认为参与动脉瘤的形成,因为它能够在主动脉壁中诱导并持续炎症反应。由于肾素的激活是肾素-血管紧张素系统的第一步,抑制肾素可以有效抑制该系统的所有成分。因此,我们使用兔模型检验了直接抑制肾素活性可减少主动脉瘤扩张的假说。通过在兔腹主动脉周围孵育弹性蛋白酶来诱导主动脉扩张。在与弹性蛋白酶孵育前1周开始持续给予直接肾素抑制剂阿利吉仑,并持续5周。阿利吉仑治疗显著抑制了组织肾素激活,并导致动脉瘤壁中血管紧张素I和II的产生显著减少。因此,肾素活性的抑制阻止了与中层保留相关的实验性主动脉瘤的扩张,这与其降压作用无关。给予阿利吉仑导致核因子κB(NF-κB)、激活蛋白-1(AP-1)和cAMP反应元件结合蛋白(CREB)的激活受到抑制,这些蛋白被认为共同调节与动脉瘤形成相关的炎症基因表达谱。结果,阿利吉仑治疗通过抑制单核细胞趋化蛋白-1(MCP-1)和C-C基序趋化因子配体4(CCL4)的表达抑制了巨噬细胞聚集,并且动脉瘤壁中肿瘤坏死因子-α(TNF-α)的产生以及基质金属蛋白酶-2(MMP-2)和基质金属蛋白酶-9(MMP-9)的产生和激活也受到抑制。此外,在阿利吉仑治疗后还观察到(前)肾素受体升高受到抑制。使用阿利吉仑直接抑制肾素活性可阻止主动脉瘤的进展,表明它是治疗腹主动脉瘤的一种治疗选择。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验